Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sanofi: Wearables are a core part of our digital trials strategy

Pharma firm partners with Parexel on patient sensor work

Sanofi

Sanofi is looking to wearable devices to improve the way it collects data and increase the effectiveness and efficacy of its clinical trial management.

The pharma firm has partnered with service company Parexel, work that begins with a proof of concept study of patient sensors.

Lionel Bascles, global head of clinical sciences and operations at Sanofi, said: “Our objective is to demonstrate the relevance of data collected remotely and the overall feasibility of utilising wearables in clinical trials.

“Wearables are a core component of Sanofi’s digital trials strategy, and represent an important approach to automate patient processes using the latest technologies to bring new therapies to patients sooner.”

Sanofi and Parexel are collaborating on a pilot study of the latter’s patient sensor solution that they hope will demonstrate the scientific and medical viability of using wearables in a clinical trial setting.

In particular they will examine how data from several wearables can be combined into “a single, scalable data system”.

Parexel Informatics president Xavier Flinois said: “We believe the use of wearables to collect data from trial participants represents a breakthrough in the digital transformation within the industry.”

19th July 2017

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics